Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status report
- 25 July 1988
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (3), B37-B43
- https://doi.org/10.1016/s0002-9149(88)80049-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucolThe American Journal of Cardiology, 1988
- Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transferThe American Journal of Cardiology, 1988
- Probucol enhances cholesterol efflux from cultured human skin fibroblastsThe American Journal of Cardiology, 1988
- Probucol quantitative regression Swedish trial: New angiographic technique to measure atheroma volume of the femoral arteryThe American Journal of Cardiology, 1988
- Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesionsThe American Journal of Cardiology, 1988
- Prevention of atherosclerotic progression in Watanabe rabbits by probucolThe American Journal of Cardiology, 1988
- In vivo inhibition of foam cell development by probucol in Watanabe rabbitsThe American Journal of Cardiology, 1988
- Controlled studies of the efficacy and safety of combined probucol-colestipol therapyThe American Journal of Cardiology, 1986